Chin Hur, MD
Overview
Dr. Chin Hur is both a physician and a research scientist. He is a recognized expert in cancer screening and prevention for gastrointestinal cancers and is a leader within a National Cancer Institute consortium of reseachers that work towards improving cancer management.
Dr. Hur has seen thousands of patients for both clinic visits and endoscopy for cancer screening and disease monitoring. He is fully committed to providing the best care possible to each patient he sees as well as improving cancer screening and prevention through his research.
His clinical and research interests keep him fully abreast of the latest technologies and improvements to patient management thereby letting him provide the most up to date care for his patients.
Areas of Expertise / Conditions Treated
- Barrett's Esophagus
- Colon Cancer
- Colon Cancer Screening
- Cyclic Vomiting Syndrome (CVS)
- Eosinophilic Esophagitis
- Esophageal Disease
- General Gastroenterology
- H. Pylori Infection
- Peptic Ulcer Disease
- Peroral Endoscopic Myotomy (POEM)
- Positive Cologuard
- Schatzki Ring
- Stomach Cancer
- Zenker's Diverticulum
Academic Appointments
- Professor of Medicine
- Professor of Epidemiology
Administrative Titles
- Director, Healthcare Innovations Research and Evaluation
Hospital Affiliations
- NewYork-Presbyterian / Columbia University Irving Medical Center
Gender
- Male
Schedule an Appointment
Virtual Visits/Telehealth
Virtual Visits allow you to connect with your provider from the comfort, convenience, and safety of your own home.
Phone Appointments
Connect Patient Portal
For existing patients, login to make an appointment, view documentation or contact your care provider.
Location(s)
Insurance Accepted
Aetna
- Aetna Signature Administrators
- EPO
- HMO
- Medicare Managed Care
- NYP Employee Plan
- NY Signature
- PPO
- Student Health
Affinity Health Plan
- Essential Plan
- Medicaid Managed Care
AgeWell
- Medicare Managed Care
- Special Needs
Amerigroup of New Jersey
- New Jersey Services (Medicaid Managed Care)
Cigna
- EPO
- Great West (National)
- HMO
- Medicare Managed Care
- POS
- PPO
Emblem/GHI
- Medicare Managed Care
- PPO
Emblem/HIP
- ConnectiCare
- EPO
- Essential Plan
- HMO
- Medicare Managed Care
- POS
- PPO
- Select Care (Exchange)
- Vytra
Empire Blue Cross Blue Shield HealthPlus
- Child/Family Health Plus
- Essential Plan
Fidelis Care
- Essential Plan
- Medicaid Managed Care
- Medicare Managed Care
Healthfirst
- Child/Family Health Plus
- Leaf (Exchange)
- Medicaid Managed Care
- Medicare Managed Care
Local 1199
- Local 1199
MagnaCare (National)
- MagnaCare
Medicare
- Railroad
- Traditional Medicare
Multiplan
- Multiplan
MVP Health Care
- Child/Family Health Plus
- Essential Plan
- HMO
- Medicaid Managed Care
Quality Health Management
- Quality Health Management
RiverSpring
- Special Needs
UnitedHealthcare
- Compass (Exchange)
- Empire Plan
- HMO
- Medicaid (Community Plan)
- Oxford Freedom
- Oxford HMO
- Oxford Liberty
- POS
- PPO
VNSNY CHOICE
- SelectHealth
WellCare
- Medicare Managed Care
World Trade Center Health Plan
- World Trade Center Health Plan
Credentials & Experience
Education & Training
- 1995 Johns Hopkins University School of Medicine
- MPH, 1995 Johns Hopkins University School of Medicine
- Residency: Johns Hopkins Hospital
- Fellowship: Beth Israel Deaconess Medical Center
Board Certifications
- Gastroenterology
- Internal Medicine
Research
I am a practicing gastroenterologist and a cancer health outcomes researcher. I am a physician scientist and a Professor of Medicine and Epidemiology at Columbia University and co-leader of the Prevention, Control, and Disparities Program for the Herbert Irving Comprehensive Cancer Center at Columbia. Since 2010, I have served on the NCI’s Cancer Intervention and Surveillance Modeling Network (CISNET) steering committee. Many of our modeling analyses have made significant contributions to inform clinical and public policy guidelines. I have experience in simulation modeling related to gastrointestinal cancers and also in many other areas such as outcomes and cost-effectiveness analyses that help test clinical management strategies in celiac disease. The overarching goal of my research as a physician-scientist is to improve clinical care for patients with cancer and to improve cancer control on a population level. I propose to achieve this goal by performing analyses that leverage the diverse health outcomes methods and techniques that my research team and I have gained expertise in.
Selected Publications
Jang SR, Truong H, Oh A, Choi J, Tramontano AC, Laszkowska M, Hur C. Cost-effectiveness Evaluation of Targeted Surgical and Endoscopic Therapies for Early Colorectal Adenocarcinoma Based on Biomarker Profiles.JAMA Netw Open. 2020 Mar 2;3(3):e1919963. doi: 10.1001/jamanetworkopen.2019.19963. PMID: 32150269
Laszkowska M, Oh A, Hur C. Screening for Upper Gastrointestinal Malignancies in the United States-Which Immigrant Groups Should Be Considered High-Risk? Gastroenterology. 2020 Jan;158(1):4-8. doi: 10.1053/j.gastro.2019.09.047. PMID: 31614125
Chu JN, Choi J, Ostvar S, Torchia JA, Reynolds KL, Tramontano A, Gainor JF, Chung DC, Clark JW, Hur C. Cost-effectiveness of immune checkpoint inhibitors for microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer. Cancer. 2019 Jan 15;125(2):278-289. PMID: 30343509
For a complete list of publications, please visit PubMed.gov
Global Health Activities
Dr. Hur has traveled to numerous countries to do research in endoscopic screening and management for gastrointestinal cancers. He has been to Korea, Japan and China where he has given presentations.
